Panagora Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Panagora Asset Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-31,034	Closed	-$580K	–	1536
2021 Q4	$580K	Buy	31,034 +125	+0.4%	+$2.44K	﹤0.01%	1157
2021 Q3	$610K	Hold	30,909	–	–	﹤0.01%	1221
2021 Q2	$731K	Sell	30,909 -6,221	-17%	-$144K	﹤0.01%	1160
2021 Q1	$880K	Buy	37,130 +36,742	+9,470%	+$873K	﹤0.01%	1076
2020 Q4	$8K	Sell	388 -4,739	-92%	-$92.5K	﹤0.01%	2331
2020 Q3	$107K	Sell	5,127 -65,932	-93%	-$1.19M	﹤0.01%	1767
2020 Q2	$1.24M	Sell	71,059 -81,528	-53%	-$1.6M	0.01%	855
2020 Q1	$2.49M	Sell	152,587 -182,290	-54%	-$3.76M	0.02%	530
2019 Q4	$6.89M	Buy	334,877 +139,121	+71%	+$2.32M	0.03%	408
2019 Q3	$2.25M	Buy	195,756 +49,206	+34%	+$562K	0.01%	701
2019 Q2	$1.93M	Buy	146,550 +76,223	+108%	+$1.02M	0.01%	848
2019 Q1	$1.06M	Buy	70,327 +63,549	+938%	+$1.02M	﹤0.01%	1095
2018 Q4	$116K	Buy	+6,778	New	+$116K	﹤0.01%	1778
2016 Q1	–	Sell	-8,742	Closed	-$240K	–	2301
2015 Q4	$240K	Buy	+8,742	New	+$184K	﹤0.01%	1540

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Panagora Asset Management's COLL Position: Q1 2022 in Review

Panagora Asset Management sold out of Collegium Pharmaceutical (COLL) in Q1 2022, closing a stake of 31,034 shares — an estimated $580K sold.

Panagora Asset Management first reported a position in COLL in Q4 2015 and held it in 14 quarters. The position peaked at $6.89M in Q4 2019. 172 funds tracked by Wall St. Rank hold COLL as of Q1 2022.

Panagora Asset Management reported no remaining Collegium Pharmaceutical position as of Q1 2022 after selling out during the quarter.
Panagora Asset Management sold 31,034 Collegium Pharmaceutical shares in Q1 2022, an estimated $580K.
Panagora Asset Management first reported a position in Collegium Pharmaceutical in Q4 2015 and held it in 14 quarters.
Panagora Asset Management's Collegium Pharmaceutical position peaked at $6.89M in Q4 2019.
172 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2022.

Based on Panagora Asset Management's 13F filing for Q1 2022, filed 12 May 2022.